section name header

Pronunciation

ox-kar-BAZ-e-peen

Classifications

Therapeutic Classification: anticonvulsants

Pharmacologic Classification: carbamazepine analogues

Indications

BEERS REMS


Unlabeled Use:

Action

  • Blocks sodium channels in neural membranes, stabilizing hyperexcitable states, inhibiting repetitive neuronal firing, and decreasing propagation of synaptic impulses.
Therapeutic effects:
  • Decreased incidence of seizures.

Pharmacokinetics

Absorption: Rapidly absorbed after oral administration and rapidly converted to the active 10-hydroxy metabolite (MHD).

Distribution: Extensively distributed to tissues.

Metabolism/Excretion: Extensively converted to the active metabolite, MHD, which is then primarily excreted by the kidneys.

Half-Life: Oxcarbazepine: 2 hr; MHD: 9 hr.

Time/Action Profile

(blood levels)

ROUTEONSETPEAKDURATION
POPOrapid4.5 hr



Steady-state levels of MHD are reached after 2–3 days during twice-daily dosing.



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Route/Dosage

Renal Impairment

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Oxtellar XR, Trileptal